Answers are grounded in this paper and cite their sources.
Cross-sectional survey assesses smartphone app usage for managing type 2 diabetes in an urban population, highlighting barriers and willingness.
Background: Diabetes is a common and serious health problem worldwide, causing millions of deaths each year. Smartphone applications offer potential benefits in education, risk mitigation, diagnosis, self-care, and treatment. However, adoption and sustained use of diabetes management apps are limited due to some barriers including technological challenges, patient-related concerns, healthcare system limitations, and behavioral factors. This study aims to assess the current usage of smartphone apps among type 2 diabetes mellitus (T2DM) patients in an urban population of Delhi, India. T2DM. Materials and Methods: The cross-sectional observational study was conducted on 530 patients with T2DM from January 2022 to December 2022 in the Northern region of India, T2DM. Data were collected using a structured digital questionnaire and analyzed to provide insights into digital health utilization. Results: The study found that 55.1% of participants actively used smartphone applications for T2DM management, demonstrating significant adoption, whereas 36.4% did not use such apps, and 8.5% were uncertain. Confidence levels in using these applications varied, with 42.3% reporting high confidence and 4.7% expressing very low confidence. Notably, 92.5% of respondents were willing to seek assistance from personal networks for managing T2DM through smartphones. In addition, 63.0% showed a moderate intent to use these applications in the future. Conclusion: The study underscores the need for enhanced education and support to bridge knowledge gaps and promote broader adoption of mHealth tools.
No takes yet. Share an insight, caveat, or question.
Saxena et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: